Glen Eagle Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.23K | Hold |
|
|||||
|
2025
Q2 | $2.68K | Hold |
|
|||||
|
2025
Q1 | $2.46K | Hold |
|
|||||
|
2024
Q4 | $3.53K | Hold |
|
|||||
|
2024
Q3 | $2.88K | Hold |
|
|||||
|
2024
Q2 | $2.6K | Hold |
|
|||||
|
2024
Q1 | $2.26K | Hold |
|
|||||
|
2023
Q4 | $1.67K | Hold |
|
|||||
|
2023
Q3 | $1.63K | Hold |
|
|||||
|
2023
Q2 | $1.21K | Hold |
|
|||||
|
2023
Q1 | $1.42K | Hold |
|
|||||
|
2022
Q4 | $1.46K | Hold |
|
|||||
|
2022
Q3 | $1.29K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $3.38K | Hold |
|
|||||
|
2020
Q3 | $3.15K | Hold |
|
|||||
|
2020
Q2 | $4.32K | Buy |
|
|||||
|
2020
Q1 | $1.35K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $941 | Hold |
|
|||||
|
2018
Q3 | $1.31K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.71K | Hold |
|
|||||
|
2017
Q4 | $1.9K | Sell |
|
|||||
|
2017
Q3 | $16.7K | Sell |
|
|||||
|
2017
Q2 | $38.2K | Sell |
|
|||||
|
2017
Q1 | $223K | Buy |
|
|||||
|
2016
Q4 | $229K | Buy |
|